KURA ONCOLOGY INC. - COMMON STOCK

NetDania - New 12 months Low: KURA ONCOLOGY INC. - COMMON STOCK

10 Jan 2025 09:45:05 By NetDania Notify

NetDania - New 12 months Low: KURA ONCOLOGY INC. - COMMON STOCK

08 Jan 2025 09:45:16 By NetDania Notify

NetDania - New 12 months Low: KURA ONCOLOGY INC. - COMMON STOCK

07 Jan 2025 09:45:07 By NetDania Notify

Kura Oncology Announces Senior Executive Promotions

06 Jan 2025 16:30:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: KURA ONCOLOGY INC. - COMMON STOCK

30 Dec 2024 09:45:21 By NetDania Notify

NetDania - New 12 months Low: KURA ONCOLOGY INC. - COMMON STOCK

27 Dec 2024 10:30:03 By NetDania Notify

NetDania - New 12 months Low: KURA ONCOLOGY INC. - COMMON STOCK

24 Dec 2024 10:21:06 By NetDania Notify

NetDania - New 12 months Low: KURA ONCOLOGY INC. - COMMON STOCK

23 Dec 2024 10:05:39 By NetDania Notify

NetDania - New 12 months Low: KURA ONCOLOGY INC. - COMMON STOCK

19 Dec 2024 09:53:07 By NetDania Notify

NetDania - New 12 months Low: KURA ONCOLOGY INC. - COMMON STOCK

18 Dec 2024 14:24:10 By NetDania Notify

NetDania - New 12 months Low: KURA ONCOLOGY INC. - COMMON STOCK

13 Dec 2024 09:45:27 By NetDania Notify

NetDania - New 12 months Low: KURA ONCOLOGY INC. - COMMON STOCK

12 Dec 2024 13:14:10 By NetDania Notify

Kura Oncology and Kyowa Kirin Report Positive Combination Data for Ziftomenib at American Society of Hematology Annual Meeting

09 Dec 2024 07:00:00 By Nasdaq GlobeNewswire

Kura Oncology to Host Virtual Investor Event on December 9, 2024

02 Dec 2024 07:30:00 By Nasdaq GlobeNewswire

Kura Oncology to Participate in JMP Securities Hematology and Oncology Summit

25 Nov 2024 07:30:00 By Nasdaq GlobeNewswire

Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias

20 Nov 2024 17:00:00 By Nasdaq GlobeNewswire

Kura Oncology Reports Third Quarter 2024 Financial Results

07 Nov 2024 16:05:01 By Nasdaq GlobeNewswire

Kura Oncology to Present Updated Data from KOMET-007 Combination Trial of Ziftomenib at ASH Annual Meeting

05 Nov 2024 09:09:54 By Nasdaq GlobeNewswire

Kura Oncology to Report Third Quarter 2024 Financial Results

31 Oct 2024 07:30:00 By Nasdaq GlobeNewswire

Kura Oncology Reports Preclinical Data Supporting Opportunity for Ziftomenib in Treatment of Gastrointestinal Stromal Tumors (GIST)

24 Oct 2024 07:30:00 By Nasdaq GlobeNewswire